Search - tctmd.com

Displaying 161 - 180 of 434

Sort: Relevancy | Date

Two Small Series Support Role for Cerebral Protection in TAVR

Michael O'Riordan

November 18, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

Presentation TCT Abstracts Posters 2019

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

Presenter: Michael DiVita

October 09, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Conference News TCT 2019

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Michael O'Riordan

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

Caitlin E. Cox

August 27, 2019

News Daily News

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

Michael O'Riordan

August 22, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Daily News

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Shelley Wood

June 27, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

Advertisement

Two Small Series Support Role for Cerebral Protection in TAVR

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Manual Hemostasis of Percutaneous Axillary Artery Access Following Intra-Aortic Balloon Pump (IABP) Insertion

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Oral Anticoagulation After TAVR Doesn’t Reduce Ischemic Cerebral Lesions: AUREA

Portico Noninferior to Commercial TAVR Valves in IDE Study

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

TCT 2019 Day Two: Transcatheter Valves, New and Old

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Oral Anticoagulation Post-AVR Safe but Not Routinely Needed: PARTNER II

FDA: Class I Recall for Burst Balloons With Sapien 3 Ultra Delivery System

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content